Brain-Derived Neurotrophic Factor in Neonatal Seizures

Area of Science:

• Neuroscience
• Developmental Biology
• Neurology

Background:

• Brain-derived neurotrophic factor (BDNF) is vital for neuronal development, survival, and plasticity.
• BDNF and its receptor, tyrosine receptor kinase B (TrkB), are critical for synapse formation and maturation.
• Research has primarily focused on decreased BDNF in neurological disorders, overlooking heightened activity.

Purpose of the Study:

• To review the role of BDNF-TrkB signaling in the immature brain.
• To examine the contribution of excessive BDNF-TrkB activity to refractory neonatal seizures.
• To explore targeting BDNF-TrkB signaling as a potential antiseizure therapy.

Main Methods:

• Literature review of preclinical and clinical studies.
• Critical analysis of existing research on BDNF-TrkB signaling pathways.
• Synthesis of findings related to neonatal seizures and BDNF-TrkB activity.

Main Results:

• Decreased BDNF is linked to synaptic deficits in neurological disorders.
• Excessive BDNF-TrkB signaling in the developing brain may induce hyperexcitability.
• This hyperexcitability is implicated in the pathophysiology of refractory neonatal seizures.

Conclusions:

• Heightened BDNF-TrkB signaling presents a potential mechanism for neonatal seizures.
• Targeting the BDNF-TrkB pathway offers a novel therapeutic avenue for refractory neonatal seizures.
• Further research is warranted to validate BDNF-TrkB as an antiseizure strategy.